Bachem Holding AGBCHMF 91 Gross Margin % is 28.70% as of Dec. 2025, which is 8% below its 10-year median of 31.14. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $98.14 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 738 Biotechnology companies, Bachem Holding AG ranks worse than 77.24% on this metric.
Bachem Holding AG gross margin has been in long-term decline. The average rate of decline per year is -2.5%.
The historical rank and industry rank for Bachem Holding AG's Gross Margin % or its related term are showing as below:
BCHMF'
s Gross Margin % Range Over the Past 10 Years
Min: 28.74 Med: 31.14 Max: 33.13
Current: 28.74
During the past 13 years, the highestGross Margin % of Bachem Holding AG was 33.13%. The lowest was 28.74%. And the median was 31.14%.
BCHMF's Gross Margin % is ranked worse than 77.24% of 738
companies
in the Biotechnology industry
Industry Median: 60.94
vs BCHMF: 28.74
Bachem Holding AG had a gross margin of 28.70% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Bachem Holding AG was -2.50% per year.
Bachem Holding AG (OTCPK:BCHMF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bachem Holding AG had a gross margin of 28.70% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bachem Holding AG Gross Margin % Related Terms
Bachem Holding AG Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BCHMF vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Bachem Holding AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bachem Holding AG (BCHMF) has a Gross Margin % of 28.70% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bachem Holding AG and its competitors. This is near median its historical median of 31.14. Over the past decade, Bachem Holding AG's Gross Margin % has ranged from 28.74 to 33.13. According to the industry distribution chart, Bachem Holding AG ranks #570 out of 738 companies in the Biotechnology industry, placing it in the top 77.2%.
Is Bachem Holding AG's Gross Margin % too high?
Bachem Holding AG's current Gross Margin % of 28.70% is near median its 10-year median of 31.14. Over the past 10 years, this metric has ranged from a low of 28.74 to a high of 33.13. The Biotechnology industry median Gross Margin % is 60.94. Bachem Holding AG's value of 28.70% is 52.9% below this industry median. Based on the distribution chart, Bachem Holding AG ranks #570 out of 738 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #570 out of 738 companies for Gross Margin %. This places Bachem Holding AG in the lower half of its industry. The industry median Gross Margin % is 60.94. Bachem Holding AG's value of 28.70% is 52.9% below this benchmark. Historically, Bachem Holding AG's own Gross Margin % has ranged from 28.74 to 33.13 over the past decade. While the company's 10-year median is 31.14 vs. the industry median of 60.94, Bachem Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.94, based on 738 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bachem Holding AG's current Gross Margin % of 28.70% is 52.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bachem Holding AG and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bachem Holding AG's current Gross Margin % is 28.70%, which is near median its own 10-year median of 31.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.14, compared to a current price of $87.34 — trading 11% below its estimated fair value. The current Gross Margin % is 28.70%, which is near median its 10-year median of 31.14 and 52.9% below the Biotechnology industry median of 60.94. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Gross Margin % is 28.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 11% below its estimated GF Value™ of $98.14.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
Gross Margin %: 28.70% (near median its 10-year median of 31.14)
GF Value™: $98.14 vs. price of $87.34 (11% below fair value)
Industry Position: 52.9% below the Biotechnology median (#570 of 738)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score
Get the complete analysis for BCHMF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
